WES of the sporadic CMML control case identified five mutations: ASXL1, NRAS, RUNX1, SRSF2, and TET2 (c.3259del, p.Ser1087LeufsTer19; VAF, 84.1%). This evidence concerns the gene ASXL1 and chronic myelomonocytic leukemia.